654 related articles for article (PubMed ID: 16682543)
21. TI-relaxation time changes over five years in relapsing-remitting multiple sclerosis.
Papadopoulos K; Tozer DJ; Fisniku L; Altmann DR; Davies G; Rashid W; Thompson AJ; Miller DH; Chard DT
Mult Scler; 2010 Apr; 16(4):427-33. PubMed ID: 20086026
[TBL] [Abstract][Full Text] [Related]
22. Relationship between MRI lesion activity and response to IFN-beta in relapsing-remitting multiple sclerosis patients.
Río J; Rovira A; Tintoré M; Huerga E; Nos C; Tellez N; Tur C; Comabella M; Montalban X
Mult Scler; 2008 May; 14(4):479-84. PubMed ID: 18562504
[TBL] [Abstract][Full Text] [Related]
23. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
[TBL] [Abstract][Full Text] [Related]
24. Quantitative diffusion weighted imaging measures in patients with multiple sclerosis.
Tavazzi E; Dwyer MG; Weinstock-Guttman B; Lema J; Bastianello S; Bergamaschi R; Cosi V; Benedict RH; Munschauer FE; Zivadinov R
Neuroimage; 2007 Jul; 36(3):746-54. PubMed ID: 17498974
[TBL] [Abstract][Full Text] [Related]
25. Evidence of thalamic gray matter loss in pediatric multiple sclerosis.
Mesaros S; Rocca MA; Absinta M; Ghezzi A; Milani N; Moiola L; Veggiotti P; Comi G; Filippi M
Neurology; 2008 Mar; 70(13 Pt 2):1107-12. PubMed ID: 18272867
[TBL] [Abstract][Full Text] [Related]
26. [Clinical assessment of the course of relapsing-remitting multiple sclerosis in patients treated with interferon beta].
Pokryszko-Dragan A; Bilińska M; Gruszka E; Dubik-Jezierzańska M
Pol Merkur Lekarski; 2005 Nov; 19(113):654-8. PubMed ID: 16498805
[TBL] [Abstract][Full Text] [Related]
27. Gray matter atrophy in multiple sclerosis: a longitudinal study.
Fisher E; Lee JC; Nakamura K; Rudick RA
Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
[TBL] [Abstract][Full Text] [Related]
28. Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study.
Calabrese M; Filippi M; Rovaris M; Bernardi V; Atzori M; Mattisi I; Favaretto A; Grossi P; Barachino L; Rinaldi L; Romualdi C; Perini P; Gallo P
Mult Scler; 2009 Jan; 15(1):36-41. PubMed ID: 18755823
[TBL] [Abstract][Full Text] [Related]
29. Regional specificity of magnetization transfer imaging in multiple sclerosis.
Tjoa CW; Benedict RH; Dwyer MG; Carone DA; Zivadinov R
J Neuroimaging; 2008 Apr; 18(2):130-6. PubMed ID: 18315593
[TBL] [Abstract][Full Text] [Related]
30. White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis.
Parry A; Clare S; Jenkinson M; Smith S; Palace J; Matthews PM
J Neurol; 2002 Sep; 249(9):1279-86. PubMed ID: 12242554
[TBL] [Abstract][Full Text] [Related]
31. Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis.
Filippi M; Rocca MA; Martino G; Horsfield MA; Comi G
Ann Neurol; 1998 Jun; 43(6):809-14. PubMed ID: 9629851
[TBL] [Abstract][Full Text] [Related]
32. Histogram analysis of diffusion measures in clinically isolated syndromes and relapsing-remitting multiple sclerosis.
Yu CS; Lin FC; Liu Y; Duan Y; Lei H; Li KC
Eur J Radiol; 2008 Nov; 68(2):328-34. PubMed ID: 17928182
[TBL] [Abstract][Full Text] [Related]
33. Association between MRI parameters and the MS severity scale: a 12 year follow-up study.
Minneboo A; Uitdehaag BM; Jongen P; Vrenken H; Knol Dl; van Walderveen MA; Polman CH; Castelijns JA; Barkhof F
Mult Scler; 2009 May; 15(5):632-7. PubMed ID: 19389751
[TBL] [Abstract][Full Text] [Related]
34. Local magnetization transfer ratio signal inhomogeneity is related to subsequent change in MTR in lesions and normal-appearing white-matter of multiple sclerosis patients.
Chen JT; Collins DL; Freedman MS; Atkins HL; Arnold DL;
Neuroimage; 2005 May; 25(4):1272-8. PubMed ID: 15850745
[TBL] [Abstract][Full Text] [Related]
35. Relapses and subsequent worsening of disability in relapsing-remitting multiple sclerosis.
Young PJ; Lederer C; Eder K; Daumer M; Neiss A; Polman C; Kappos L;
Neurology; 2006 Sep; 67(5):804-8. PubMed ID: 16966541
[TBL] [Abstract][Full Text] [Related]
36. Measuring demyelination and remyelination in acute multiple sclerosis lesion voxels.
Giacomini PS; Levesque IR; Ribeiro L; Narayanan S; Francis SJ; Pike GB; Arnold DL
Arch Neurol; 2009 Mar; 66(3):375-81. PubMed ID: 19273757
[TBL] [Abstract][Full Text] [Related]
37. Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis.
Battaglini M; Giorgio A; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
J Neurol Sci; 2009 Jul; 282(1-2):55-60. PubMed ID: 19286193
[TBL] [Abstract][Full Text] [Related]
38. Cervical cord magnetization transfer ratio and clinical changes over 18 months in patients with relapsing-remitting multiple sclerosis: a preliminary study.
Charil A; Caputo D; Cavarretta R; Sormani MP; Ferrante P; Filippi M
Mult Scler; 2006 Oct; 12(5):662-5. PubMed ID: 17086915
[TBL] [Abstract][Full Text] [Related]
39. Patients' stratification and correlation of brain magnetic resonance imaging parameters with disability progression in multiple sclerosis.
Vaneckova M; Seidl Z; Krasensky J; Havrdova E; Horakova D; Dolezal O; Burgetova A; Masek M
Eur Neurol; 2009; 61(5):278-84. PubMed ID: 19295214
[TBL] [Abstract][Full Text] [Related]
40. A magnetization transfer MRI study of deep gray matter involvement in multiple sclerosis.
Sharma J; Zivadinov R; Jaisani Z; Fabiano AJ; Singh B; Horsfield MA; Bakshi R
J Neuroimaging; 2006 Oct; 16(4):302-10. PubMed ID: 17032378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
